Organon & Co | OGN - Market Capitalization


Organon & Co reported $3.52B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Cspc Pharmaceutical CNY 99.86B 3.93B Aug/2026
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 4.58B 2.8B Mar/2026
Divis Laboratories Ltd INR 2.21T 464.84B Aug/2026
Gilead Sciences USD 168.68B 11.82B Aug/2026
Glaxosmithkline GBP 109.29B 9.36B Mar/2026
Kangmei Pharma CNY 24.48B 3.45B Mar/2026
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Malin Corporation EUR 133.52M 29.05M Aug/2026
Medical Developments International AUD 37.11M 25.41M Aug/2026
Merck USD 324.18B 6.81B Aug/2026
Neuren Pharmaceuticals AUD 2.44B 80.57M Aug/2026
Novartis USD 288.26B 25.18B Mar/2026
Organigram Holdings CAD 252.47M 59.69M Mar/2026
Organon & Co USD 3.51B 52.64M Aug/2026
Ovoca Bio EUR 5.1M 3.93M Aug/2026
Pharma Mar EUR 1.39B 78.26M Aug/2026
Qiagen NV USD 8.47B 396.81M Aug/2026
Sartorius EUR 15.63B 1.38B Jun/2026
Zealand Pharma A/S 33.35B 12.51B Aug/2026